Evidence map›Paper›PMID 41720887›Full record

ArticleScientific reports2026

Assessing anaerobe detection in routine sputum analyses from cystic fibrosis patients.

Alice Clarenne, Lourdes Velo Suarez, Anaëlle Muggeo, Julie Meurice, Quentin Lecomte-Thenot, Jeanne-Marie Perotin, Katia Bessaci-Kabouya, Pauline Mulette, Michel Abely, Stéphanie Gouriou and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Alice ClarenneCHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, Reims, France.
Lourdes Velo SuarezUniv Brest, Inserm, EFS, UMR 1078, GGB, 29200, Brest, France.
Anaëlle MuggeoUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, P3Cell, UMR-S 1250, 45, rue Cognacq-Jay, 51092, Reims Cedex, France.
Julie MeuriceCHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, Reims, France.
Quentin Lecomte-ThenotCHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, Reims, France.
Jeanne-Marie PerotinUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Service des Maladies Respiratoires, P3Cell, U 1250, Reims, France.
Katia Bessaci-KabouyaUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Service de Pédiatrie, P3Cell, U 1250, Reims, France.
Pauline MuletteCHU de Reims, Centre de Ressources et de Compétences de la Mucoviscidose Mixte, American Memorial Hospital, Reims, France.
Michel AbelyUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Service de Pédiatrie, P3Cell, U 1250, Reims, France.
Stéphanie GouriouDepartment of Infectious Agents, CHU de Brest, 29200, Brest, France.
Sandra DuryCHU de Reims, Centre de Ressources et de Compétences de la Mucoviscidose Mixte, American Memorial Hospital, Reims, France.
Gaëtan DesléeUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Service des Maladies Respiratoires, P3Cell, U 1250, Reims, France.
Geneviève Héry-ArnaudUniv Brest, Inserm, EFS, UMR 1078, GGB, 29200, Brest, France.
Thomas GuillardUniversité de Reims Champagne-Ardenne, INSERM, CHU de Reims, Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, P3Cell, UMR-S 1250, 45, rue Cognacq-Jay, 51092, Reims Cedex, France. tguillard@chu-reims.fr.

Funding

Université de Reims Champagne-Ardenne RINNOPARIUniversity Hospital of Reims RINNOPARI
6 · The paper itself

Abstract

Pulmonary involvement in cystic fibrosis (CF) includes bronchiectasis and chronic airway infection, with nearly half of the airway bacteria being anaerobes. Some anaerobic species, such as Porphyromonas catoniae, have been identified as predictive biomarkers for Pseudomonas aeruginosa colonization, with P. catoniae decreasing as the disease progresses. Although 16S rRNA metagenomics offers a comprehensive view of airway anaerobes, it is not routinely performed in clinical microbiology laboratories. This study aimed to evaluate the ability of routine sputum culture to identify strict anaerobes in people with CF (pwCF) compared to 16S rRNA sequencing, and to assess the impact of sample transport conditions. Sputum from 48 pwCF was analyzed by anaerobic culture and 16S rRNA sequencing. Strict anaerobes were detected in 95.8% of patients by culture and 100% by 16S rRNA sequencing. Culture identified 23 strict anaerobic species (mean 2.6 per sample), while 16S rRNA sequencing revealed nearly 100 species (mean 43 per sample). Importantly, culture isolated key genera such as Veillonella and Prevotella, core members of the CF airway anaerobiome. Transport conditions (aerobic vs. anaerobic) did not affect anaerobe detection. These new findings support changes in the processing of CF sputum in the everyday practice of clinical microbiology laboratories and promote the characterization of the culturable anaerobic airway microbiota.

Indexed as

Bacteria, AnaerobicCystic FibrosisSputumAdultFemaleHumansMaleRNA, Ribosomal, 16SRNA, Ribosomal, 16SAnaerobesCystic fibrosisMetagenomicsStandard operating procedures

Identifiers

PMID41720887
PMCPMC13022182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.